ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monoclonal Antibody Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-9C7350
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Monoclonal Antibody Therapeutics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Monoclonal Antibody Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-9C7350
Report
September 2022
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
F.Hoffmann-La Roche
Pfizer Inc
Sanofi
GlaxoSmithKline PLC
Merck
Novartis
AbbVie
Amgen Inc
Johnson & Johnson
Bristol Myers Squibb Company
Biogen
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Monoclonal Antibody Therapeutics estimated at US$ 126390 million in the year 2022, is projected to reach a revised size of US$ 190750 million by 2028, growing at a CAGR of 7.1% during the forecast period 2022-2028.

The USA market for Monoclonal Antibody Therapeutics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Monoclonal Antibody Therapeutics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Monoclonal Antibody Therapeutics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Monoclonal Antibody Therapeutics include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie and Amgen, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Monoclonal Antibody Therapeutics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Monoclonal Antibody Therapeutics market. Further, it explains the major drivers and regional dynamics of the global Monoclonal Antibody Therapeutics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Monoclonal Antibody Therapeutics Segment by Type

Humanized Antibody
Human Mouse Chimeric Antibody

Monoclonal Antibody Therapeutics Segment by Application

Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Monoclonal Antibody Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Monoclonal Antibody Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Monoclonal Antibody Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Monoclonal Antibody Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Monoclonal Antibody Therapeutics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Monoclonal Antibody Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Monoclonal Antibody Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie and Amgen, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Monoclonal Antibody Therapeutics Market Size (2017-2028)
2.2 Monoclonal Antibody Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Monoclonal Antibody Therapeutics Market Size by Region (2017-2022)
2.4 Global Monoclonal Antibody Therapeutics Market Size Forecast by Region (2023-2028)
2.5 Global Top Monoclonal Antibody Therapeutics Countries Ranking by Market Size
3 Monoclonal Antibody Therapeutics Competitive by Company
3.1 Global Monoclonal Antibody Therapeutics Revenue by Players
3.1.1 Global Monoclonal Antibody Therapeutics Revenue by Players (2017-2022)
3.1.2 Global Monoclonal Antibody Therapeutics Market Share by Players (2017-2022)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2021
3.5 Global Monoclonal Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Monoclonal Antibody Therapeutics Breakdown Data by Type
4.1 Global Monoclonal Antibody Therapeutics Historic Revenue by Type (2017-2022)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Revenue by Type (2023-2028)
5 Global Monoclonal Antibody Therapeutics Breakdown Data by Application
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Monoclonal Antibody Therapeutics Revenue by Company (2020-2022)
6.2 North America Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
6.3 North America Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
6.4 North America Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Revenue by Company (2020-2022)
7.2 Europe Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
7.3 Europe Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
7.4 Europe Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Monoclonal Antibody Therapeutics Revenue by Company (2020-2022)
8.2 Asia Pacific Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
8.3 Asia Pacific Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
8.4 Asia Pacific Monoclonal Antibody Therapeutics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Monoclonal Antibody Therapeutics Revenue by Company (2020-2022)
9.2 Latin America Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
9.3 Latin America Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
9.4 Latin America Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Company (2020-2022)
10.2 Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
10.3 Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
10.4 Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Products and Services
11.1.4 Bayer Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.1.5 Bayer Monoclonal Antibody Therapeutics SWOT Analysis
11.1.6 Bayer Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Products and Services
11.2.4 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics SWOT Analysis
11.2.6 F. Hoffmann-La Roche Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Products and Services
11.3.4 Pfizer Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.3.5 Pfizer Monoclonal Antibody Therapeutics SWOT Analysis
11.3.6 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Products and Services
11.4.4 Sanofi Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.4.5 Sanofi Monoclonal Antibody Therapeutics SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Products and Services
11.5.4 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.5.5 GlaxoSmithKline Monoclonal Antibody Therapeutics SWOT Analysis
11.5.6 GlaxoSmithKline Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Products and Services
11.6.4 Merck Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.6.5 Merck Monoclonal Antibody Therapeutics SWOT Analysis
11.6.6 Merck Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Products and Services
11.7.4 Novartis Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.7.5 Novartis Monoclonal Antibody Therapeutics SWOT Analysis
11.7.6 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Products and Services
11.8.4 AbbVie Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.8.5 AbbVie Monoclonal Antibody Therapeutics SWOT Analysis
11.8.6 AbbVie Recent Developments
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Products and Services
11.9.4 Amgen Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.9.5 Amgen Monoclonal Antibody Therapeutics SWOT Analysis
11.9.6 Amgen Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Products and Services
11.10.4 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.10.5 Johnson & Johnson Monoclonal Antibody Therapeutics SWOT Analysis
11.10.6 Johnson & Johnson Recent Developments
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Products and Services
11.11.4 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.11.5 Bristol-Myers Squibb Company Recent Developments
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Monoclonal Antibody Therapeutics Products and Services
11.12.4 Biogen Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
11.12.5 Biogen Recent Developments
12 Monoclonal Antibody Therapeutics Market Dynamics
12.1 Monoclonal Antibody Therapeutics Market Trends
12.2 Monoclonal Antibody Therapeutics Market Drivers
12.3 Monoclonal Antibody Therapeutics Market Challenges
12.4 Monoclonal Antibody Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
FEATURED COMPANIES
Bayer
F.Hoffmann-La Roche
Pfizer Inc
Sanofi
GlaxoSmithKline PLC
Merck
Novartis
AbbVie
Amgen Inc
Johnson & Johnson
Bristol Myers Squibb Company
Biogen
List of Tables
    Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Humanized Antibody
    Table 3. Key Players of Human Mouse Chimeric Antibody
    Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Monoclonal Antibody Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 6. Global Monoclonal Antibody Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 7. Global Monoclonal Antibody Therapeutics Revenue Market Share by Region (2017-2022)
    Table 8. Global Monoclonal Antibody Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 9. Global Monoclonal Antibody Therapeutics Market Share by Players (2017-2022)
    Table 10. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2021)
    Table 11. Ranking of Global Top Monoclonal Antibody Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 12. Global 5 Largest Players Market Share by Monoclonal Antibody Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 13. Key Players Headquarters and Area Served
    Table 14. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
    Table 15. Date of Key Manufacturers Enter into Monoclonal Antibody Therapeutics Market
    Table 16. Mergers & Acquisitions, Expansion Plans
    Table 17. Global Monoclonal Antibody Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 18. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2017-2022)
    Table 19. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 20. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2023-2028)
    Table 21. Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 22. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2017-2022)
    Table 23. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2023-2028)
    Table 25. North America Monoclonal Antibody Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 26. North America Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 27. North America Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 28. North America Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 29. North America Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 30. North America Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 31. North America Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 32. Europe Monoclonal Antibody Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 33. Europe Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Europe Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Europe Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 36. Europe Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 37. Europe Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Europe Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 39. Asia Pacific Monoclonal Antibody Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 40. Asia Pacific Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 41. Asia Pacific Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 42. Asia Pacific Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Asia Pacific Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Monoclonal Antibody Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Monoclonal Antibody Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 46. Latin America Monoclonal Antibody Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 47. Latin America Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 48. Latin America Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 49. Latin America Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 50. Latin America Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 51. Latin America Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 52. Latin America Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 53. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 54. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 55. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Bayer Company Details
    Table 61. Bayer Business Overview
    Table 62. Bayer Monoclonal Antibody Therapeutics Product and Services
    Table 63. Bayer Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Bayer Monoclonal Antibody Therapeutics SWOT Analysis
    Table 65. Bayer Recent Developments
    Table 66. F. Hoffmann-La Roche Company Details
    Table 67. F. Hoffmann-La Roche Business Overview
    Table 68. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product and Services
    Table 69. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics SWOT Analysis
    Table 71. F. Hoffmann-La Roche Recent Developments
    Table 72. Pfizer Company Details
    Table 73. Pfizer Business Overview
    Table 74. Pfizer Monoclonal Antibody Therapeutics Product and Services
    Table 75. Pfizer Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Pfizer Monoclonal Antibody Therapeutics SWOT Analysis
    Table 77. Pfizer Recent Developments
    Table 78. Sanofi Company Details
    Table 79. Sanofi Business Overview
    Table 80. Sanofi Monoclonal Antibody Therapeutics Product and Services
    Table 81. Sanofi Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 82. Sanofi Monoclonal Antibody Therapeutics SWOT Analysis
    Table 83. Sanofi Recent Developments
    Table 84. GlaxoSmithKline Company Details
    Table 85. GlaxoSmithKline Business Overview
    Table 86. GlaxoSmithKline Monoclonal Antibody Therapeutics Product and Services
    Table 87. GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 88. GlaxoSmithKline Monoclonal Antibody Therapeutics SWOT Analysis
    Table 89. GlaxoSmithKline Recent Developments
    Table 90. Merck Company Details
    Table 91. Merck Business Overview
    Table 92. Merck Monoclonal Antibody Therapeutics Product and Services
    Table 93. Merck Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 94. Merck Monoclonal Antibody Therapeutics SWOT Analysis
    Table 95. Merck Recent Developments
    Table 96. Novartis Company Details
    Table 97. Novartis Business Overview
    Table 98. Novartis Monoclonal Antibody Therapeutics Product and Services
    Table 99. Novartis Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. Novartis Monoclonal Antibody Therapeutics SWOT Analysis
    Table 101. Novartis Recent Developments
    Table 102. AbbVie Company Details
    Table 103. AbbVie Business Overview
    Table 104. AbbVie Monoclonal Antibody Therapeutics Product and Services
    Table 105. AbbVie Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. AbbVie Monoclonal Antibody Therapeutics SWOT Analysis
    Table 107. AbbVie Recent Developments
    Table 108. Amgen Company Details
    Table 109. Amgen Business Overview
    Table 110. Amgen Monoclonal Antibody Therapeutics Product and Services
    Table 111. Amgen Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 112. Amgen Monoclonal Antibody Therapeutics SWOT Analysis
    Table 113. Amgen Recent Developments
    Table 114. Johnson & Johnson Company Details
    Table 115. Johnson & Johnson Business Overview
    Table 116. Johnson & Johnson Monoclonal Antibody Therapeutics Product and Services
    Table 117. Johnson & Johnson Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 118. Johnson & Johnson Monoclonal Antibody Therapeutics SWOT Analysis
    Table 119. Johnson & Johnson Recent Developments
    Table 120. Bristol-Myers Squibb Company Company Details
    Table 121. Bristol-Myers Squibb Company Business Overview
    Table 122. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product and Services
    Table 123. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 124. Bristol-Myers Squibb Company Recent Developments
    Table 125. Biogen Company Details
    Table 126. Biogen Business Overview
    Table 127. Biogen Monoclonal Antibody Therapeutics Product and Services
    Table 128. Biogen Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
    Table 129. Biogen Recent Developments
    Table 130. Monoclonal Antibody Therapeutics Market Trends
    Table 131. Monoclonal Antibody Therapeutics Market Drivers
    Table 132. Monoclonal Antibody Therapeutics Market Challenges
    Table 133. Monoclonal Antibody Therapeutics Market Restraints
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Monoclonal Antibody Therapeutics Sales Market Share by Type: 2021 VS 2028
    Figure 2. Humanized Antibody Features
    Figure 3. Human Mouse Chimeric Antibody Features
    Figure 4. Global Monoclonal Antibody Therapeutics Sales Market Share by Application: 2021 VS 2028
    Figure 5. Cancer Case Studies
    Figure 6. Autoimmune Diseases Case Studies
    Figure 7. Infection Case Studies
    Figure 8. Hematological Diseases Case Studies
    Figure 9. Ophthalmological Diseases Case Studies
    Figure 10. Others Case Studies
    Figure 11. Monoclonal Antibody Therapeutics Report Years Considered
    Figure 12. Global Monoclonal Antibody Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Monoclonal Antibody Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 14. Global Monoclonal Antibody Therapeutics Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global Monoclonal Antibody Therapeutics Revenue Market Share by Region in 2017 VS 2022
    Figure 16. Global Top 10 Monoclonal Antibody Therapeutics Countries Ranking by Market Size (US$ Million) in 2021
    Figure 17. Global Monoclonal Antibody Therapeutics Market Share by Players in 2021
    Figure 18. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2021
    Figure 20. North America Monoclonal Antibody Therapeutics Revenue Market Share by Company in 2021
    Figure 21. North America Monoclonal Antibody Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 22. North America Monoclonal Antibody Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 23. North America Monoclonal Antibody Therapeutics Revenue Share by Country (2017-2028)
    Figure 24. U.S. Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 25. Canada Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 26. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Company in 2021
    Figure 27. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 28. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 29. Europe Monoclonal Antibody Therapeutics Revenue Share by Country (2017-2028)
    Figure 30. Germany Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 31. France Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 32. U.K. Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 33. Italy Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 34. Russia Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Company in 2021
    Figure 36. Asia Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Monoclonal Antibody Therapeutics Revenue Share by Region (2017-2028)
    Figure 39. China Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 40. Japan Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 41. South Korea Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 42. India Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 43. Australia Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 44. Taiwan Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 45. Indonesia Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 46. Thailand Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 47. Malaysia Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 48. Philippines Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 49. Vietnam Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 50. Latin America Monoclonal Antibody Therapeutics Revenue Market Share by Company in 2021
    Figure 51. Latin America Monoclonal Antibody Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 52. Latin America Monoclonal Antibody Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 53. Latin America Monoclonal Antibody Therapeutics Revenue Share by Country (2017-2028)
    Figure 54. Mexico Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 55. Brazil Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 56. Argentina Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Company in 2021
    Figure 58. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Share by Country (2017-2028)
    Figure 61. Turkey Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 63. U.A.E Monoclonal Antibody Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 64. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 65. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 66. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 67. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 68. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 69. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 70. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 71. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 72. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 73. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 74. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 75. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions